Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05913687 · ClinicalTrials.gov registry record
Automated Imaging Differentiation of Parkinsonism
A clinical trial of Parkinson Disease and Progressive Supranuclear Palsy, sponsored by University of Florida.
- Active
- Registry status
- 315
- Enrollment target
- 20
- Study locations
NCT05913687 is a study of Parkinson Disease and Progressive Supranuclear Palsy that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 315 participants, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (94% lower). The trial reports 20 study locations across 15 states.
The verdict
NCT05913687, a study of Parkinson Disease and Progressive Supranuclear Palsy, is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- 315 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagnostic algorithm and the imaging diagnosis will be compared to the movement disorders trained neurologist diagnosis.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST AIDP
Study Locations (20)
California
- University of California San Diego - La Jolla
- University of California San Francisco - San Francisco
Florida
- University of Florida - Gainesville
- University of South Florida - Tampa
Illinois
- Northwestern University - Chicago
- University of Chicago - Chicago
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- Massachusetts General Hospital - Charlestown
North Carolina
- Duke University Medical Center - Durham
- Wake Forest University - Winston-Salem
Alabama
- University of Alabama at Birmingham - Birmingham
Georgia
- Augusta University - Augusta
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2021-07-22 |
| Est. Completion | 2026-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05913687
The ClinicalTrials.gov registry entry for NCT05913687 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (94% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which AIDP is the first listed.
NCT05913687 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT05913687 about?
NCT05913687 is a clinical study titled "Automated Imaging Differentiation of Parkinsonism". The purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagnostic algorithm and ...
What is the current status of trial NCT05913687?
This trial is currently active not recruiting. The enrollment target is 315 participants. The study started on 2021-07-22. Estimated completion is 2026-03-31.
What conditions does trial NCT05913687 study?
This clinical trial studies the following conditions: Parkinson Disease, Progressive Supranuclear Palsy, Multiple System Atrophy, Parkinson Variant.
What interventions are being tested in trial NCT05913687?
The interventions under investigation include: AIDP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05913687?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05913687 being conducted?
This trial has 20 study locations across Alabama, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.